Intrinsic Value

The intrinsic value of Mao Bao Inc (1732) under the Base Case is 26.2 TWD per share. Compared with the current market price of 26.55 TWD, the stock appears Overvalued by 1% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

Intrinsic Value
NT$26.2
Overvaluation 1%
Intrinsic Value
Price NT$26.55

Mao Bao Inc is cheaper than usual. Still overvalued, but less so than on 94% of days in the past 5 years.

Monitor Mao Bao Inc
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value NT$20.96
Get notified when the price drops into your buy zone
Current Price NT$26.55
Intrinsic Value NT$26.2
Margin of Safety 20% NT$20.96
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Mao Bao Inc

Fundamental Analysis

What Mao Bao Does

Consumer products Consumer Staples

Mao Bao Inc is a Taiwan-based pharmaceutical company that makes and sells medicines and related health products. Its business is centered on developing, manufacturing, and packaging products that are used to treat common medical conditions, then selling them through healthcare and retail channels.

Headquarters
Taiwan TW
IPO date
Nov 22, 1999
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Mao Bao Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Mao Bao Inc stock?

The intrinsic value for Mao Bao Inc (1732) under the Base Case is 26.2 TWD.

Is Mao Bao Inc stock undervalued or overvalued?

Compared with the current market price of 26.55 TWD, the stock appears Overvalued by 1% .

Back to Top